In mortality statistics cigarette-smoking habits have been observed to be correlated with coronary heart disease (Hammond and Horn, 1954; Doll and Hill, 1956; Hammond and Horn, 1958 ); and the serum lipid level and especially the serum cholesterol and p-lipoproteins are known to be raised in population groups with coronary heart disease. With these facts in mind, many investigators have studied the relationship between cigarette smoking and the serum lipid level (Gofman et al., 1955 ; Karvonen et al., 1959 ; Thomas, 1958 Thomas, , 1960 Dawber et al., 1959; Blackburn et al., 1960; BronteStewart, 1961 (1955) found that the difference in serum lipids between smokers and non-smokers was greater in their youngest (20-29) age-group than in the older ones. In the present study the subjects were slightly younger than the youngest age-groups mentioned above. If the explanation for the difference between the observations in the mentioned studies and the present one lies in this point, the effect on serum lipids of exposure to cigarette smoking seems to occur after some years of smoking, but not, however, during so short a smoking period as in the present work.
In mortality statistics cigarette-smoking habits have been observed to be correlated with coronary heart disease (Hammond and Horn, 1954; Doll and Hill, 1956; Hammond and Horn, 1958 ); and the serum lipid level and especially the serum cholesterol and p-lipoproteins are known to be raised in population groups with coronary heart disease. With these facts in mind, many investigators have studied the relationship between cigarette smoking and the serum lipid level (Gofman et al., 1955 ; Karvonen et al., 1959 ;  Thomas, 1958 Thomas, , 1960 Dawber et al., 1959; Blackburn et al., 1960; BronteStewart, 1961 (Anderson and Keys, 1956 ) and the serum total phospholipids (Fiske and Subbarow, 1925) were determined. Serum lipo-protein fractions were separated with the aid of paper electrophoresis, and from the fractions so separated the cholesterol content of the a-and pl-lipoproteins was determined. The details and evidence of their accuracy have been presented in a previous study (Konttinen, 1959 The age range of the whole series is quite narrow (18-25 years) and there is very little difference between the groups. As the men were young they had not been smoking very long, although one criterion in selecting them was at least one year's smoking. Karvonen et al. (1959) , however, observed a higher serum cholesterol level in smokers of all age-groups, except 50-59 years, in West Finland; the youngest agegroup in their study was 20-29 years. Gofman et al. (1955) found that the difference in serum lipids between smokers and non-smokers was greater in their youngest (20-29) age-group than in the older ones. In the present study the subjects were slightly younger than the youngest age-groups mentioned above. If the explanation for the difference between the observations in the mentioned studies and the present one lies in this point, the effect on serum lipids of exposure to cigarette smoking seems to occur after some years of smoking, but not, however, during so short a smoking period as in the present work.
When considering atherosclerosis many investigators have stressed the importance of the /8: a ratio ini the lipoprotein fractions. It has been noticed that an increase in this ratio is encountered in patients with atherosclerosis (Nikkilai, 1953 ; Oliver and Boyd, 1955; Jencks et al., 1956 ). In the studies concerning the correlation between smoking and serum lipids in which lipoprotein fractions are included the p: a ratio has been found to be raised in smokers (Gofman et al., 1955; Bronte-Stewart, 1961 (Ahrens and Kunkel, 1949) , and it has therefore been inferred that an increase in the ratio of phospholipids to cholesterol helps to prevent atherosclerosis. This view has been supported by the observation that the phospholipid :cholesterol ratio is smaller in atherosclerosis than in age-matched controls (Gartler et al., 1950; Oliver and Boyd, 1953) . The published studies on the relation between serum lipids and smoking do not include reports concerning serum phospholipids. In the present study phospholipids show no trend paralleling the smoking habits.
Attempts have been made to relate the rise in serum lipids observed in the previous studies in smokers to differences in the diet possibly due to smoking. Krut et al. (1961) have noted a difference in the perception of bitter taste between smokers and non-smokers. According to those authors this could lead to smokers having a preference for some special foods. The same group of investigators have observed that smokers consumed more fat than non-smokers, but the difference was too small to explain the difference in serum lipids, and in Finland S. Punsar (unpublished data) could not detect any difference between the diet of smokers and that of non-smokers. Even the greater amount of fat consumed by smokers does not necessarily signify that all this fat is absorbed, for a recent study (Konttinen and Rajasalmi, to be published) has shown that the rise in serum triglycerides after a fatty meal is less in heavy smokers than in non-smokers.
The effect of giving up smoking should throw further light on the correlation between cigarette smoking and serum lipids, but in the only relevant report I found in the literature no change in serum cholesterol was detected in the six subjects studied (Thomas and Eisenberg, 1959) .
The possibility has also been discussed that smoking could be another manifestation of the disturbance responsible for the rise in the serum cholesterol level, and in this connexion mental tension was incriminated as the cholesterol-elevating factor (Thomas and Murphy, 1958; Wertlake et al., 1958; Grundy and Griffin, 1959; Dreyfuss and Czaczkes, 1959; Peterson et al., 1960 (Registrar-General, 1961) . Two substances are available for prophylactic treatment-tetanus antitoxin and tetanus toxoid. The former is a short-term prophylactic given at the time of wounding to effect passive immunization. Tetanus toxoid, a long-term prophylactic, is available as either alum-precipitated toxoid. used in the United States, or formol toxoid (Tet/Vac/ FT), used in this country for active immunization. A primary course consists of three subcutaneous or intramuscular injections of 1 ml. The interval between the first and second injections is 6 to 12 weeks and that between the second and third injections 6 to 12 months.
A reinforcing dose of 1 ml. every five years maintains an effective antitoxin titre.
Tetanus antitoxin may cause allergic reactions (Clarke, 1960) ; in comparison, tetanus toxoid is regarded as a safe and effective method of immunization. However, it is not generally realized that tetanus toxoid can also produce allergic reactions. Four such reactions are reported below.
